← 產業報告目錄
Home Insulin Delivery (Dosing) Devices Industry Research Report 2026
出版商 APO Research產業別 Medical Devices出版日期 2026-07-04頁數 149報告編號 APO-26e8d8c075
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Home Insulin Delivery (Dosing) Devices market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Home Insulin Delivery (Dosing) Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Home Insulin Delivery (Dosing) Devices is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Home Insulin Delivery (Dosing) Devices is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Home Insulin Delivery (Dosing) Devices include Medtronic, Ypsomed Holding, Wockhardt, West Pharma, Valeritas, Tandem Diabetes Care, SOOIL, Sanofi and Roche Holding AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Home Insulin Delivery (Dosing) Devices market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Home Insulin Delivery (Dosing) Devices Market by Company
Medtronic
Ypsomed Holding
Wockhardt
West Pharma
Valeritas
Tandem Diabetes Care
SOOIL
Sanofi
Roche Holding AG
Owen Mumford
Novo Nordisk
MannKind
Julphar
Insulet Corporation
Eli Lilly and Company
Debiotech
Dance Biopharm
Copernicus
Biocon
Beta Bionics
BD
B. Braun
Home Insulin Delivery (Dosing) Devices Segment by Type
Insulin Pumps
Insulin Pens
Insulin Syringes
Others
Home Insulin Delivery (Dosing) Devices Segment by Application
Online Pharmacy
Retail Pharmacy
Hospitals Pharmacy
Home Insulin Delivery (Dosing) Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Home Insulin Delivery (Dosing) Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Home Insulin Delivery (Dosing) Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Home Insulin Delivery (Dosing) Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Home Insulin Delivery (Dosing) Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Home Insulin Delivery (Dosing) Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Home Insulin Delivery (Dosing) Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Home Insulin Delivery (Dosing) Devices Market Size (2021-2032)
2.2.2 Global Home Insulin Delivery (Dosing) Devices Sales (2021-2032)
2.2.3 Global Home Insulin Delivery (Dosing) Devices Market Average Price (2021-2032)
2.3 Home Insulin Delivery (Dosing) Devices by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Insulin Pumps
2.3.3 Insulin Pens
2.3.4 Insulin Syringes
2.3.5 Others
2.4 Home Insulin Delivery (Dosing) Devices by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Online Pharmacy
2.4.3 Retail Pharmacy
2.4.4 Hospitals Pharmacy
3 Market Competitive Landscape by Manufacturers
3.1 Global Home Insulin Delivery (Dosing) Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Home Insulin Delivery (Dosing) Devices Sales (k units) of Manufacturers (2021-2026)
3.3 Global Home Insulin Delivery (Dosing) Devices Revenue of Manufacturers (2021-2026)
3.4 Global Home Insulin Delivery (Dosing) Devices Average Price by Manufacturers (2021-2026)
3.5 Global Home Insulin Delivery (Dosing) Devices Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Home Insulin Delivery (Dosing) Devices, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Home Insulin Delivery (Dosing) Devices, Product Type & Application
3.8 Global Manufacturers of Home Insulin Delivery (Dosing) Devices, Established Date
3.9 Global Home Insulin Delivery (Dosing) Devices Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Medtronic
4.1.1 Medtronic Company Information
4.1.2 Medtronic Business Overview
4.1.3 Medtronic Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Medtronic Home Insulin Delivery (Dosing) Devices Product Portfolio
4.1.5 Medtronic Recent Developments
4.2 Ypsomed Holding
4.2.1 Ypsomed Holding Company Information
4.2.2 Ypsomed Holding Business Overview
4.2.3 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Portfolio
4.2.5 Ypsomed Holding Recent Developments
4.3 Wockhardt
4.3.1 Wockhardt Company Information
4.3.2 Wockhardt Business Overview
4.3.3 Wockhardt Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Wockhardt Home Insulin Delivery (Dosing) Devices Product Portfolio
4.3.5 Wockhardt Recent Developments
4.4 West Pharma
4.4.1 West Pharma Company Information
4.4.2 West Pharma Business Overview
4.4.3 West Pharma Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.4.4 West Pharma Home Insulin Delivery (Dosing) Devices Product Portfolio
4.4.5 West Pharma Recent Developments
4.5 Valeritas
4.5.1 Valeritas Company Information
4.5.2 Valeritas Business Overview
4.5.3 Valeritas Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Valeritas Home Insulin Delivery (Dosing) Devices Product Portfolio
4.5.5 Valeritas Recent Developments
4.6 Tandem Diabetes Care
4.6.1 Tandem Diabetes Care Company Information
4.6.2 Tandem Diabetes Care Business Overview
4.6.3 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Portfolio
4.6.5 Tandem Diabetes Care Recent Developments
4.7 SOOIL
4.7.1 SOOIL Company Information
4.7.2 SOOIL Business Overview
4.7.3 SOOIL Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.7.4 SOOIL Home Insulin Delivery (Dosing) Devices Product Portfolio
4.7.5 SOOIL Recent Developments
4.8 Sanofi
4.8.1 Sanofi Company Information
4.8.2 Sanofi Business Overview
4.8.3 Sanofi Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.8.4 Sanofi Home Insulin Delivery (Dosing) Devices Product Portfolio
4.8.5 Sanofi Recent Developments
4.9 Roche Holding AG
4.9.1 Roche Holding AG Company Information
4.9.2 Roche Holding AG Business Overview
4.9.3 Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Portfolio
4.9.5 Roche Holding AG Recent Developments
4.10 Owen Mumford
4.10.1 Owen Mumford Company Information
4.10.2 Owen Mumford Business Overview
4.10.3 Owen Mumford Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.10.4 Owen Mumford Home Insulin Delivery (Dosing) Devices Product Portfolio
4.10.5 Owen Mumford Recent Developments
4.11 Novo Nordisk
4.11.1 Novo Nordisk Company Information
4.11.2 Novo Nordisk Business Overview
4.11.3 Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.11.4 Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Portfolio
4.11.5 Novo Nordisk Recent Developments
4.12 MannKind
4.12.1 MannKind Company Information
4.12.2 MannKind Business Overview
4.12.3 MannKind Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.12.4 MannKind Home Insulin Delivery (Dosing) Devices Product Portfolio
4.12.5 MannKind Recent Developments
4.13 Julphar
4.13.1 Julphar Company Information
4.13.2 Julphar Business Overview
4.13.3 Julphar Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.13.4 Julphar Home Insulin Delivery (Dosing) Devices Product Portfolio
4.13.5 Julphar Recent Developments
4.14 Insulet Corporation
4.14.1 Insulet Corporation Company Information
4.14.2 Insulet Corporation Business Overview
4.14.3 Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.14.4 Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Portfolio
4.14.5 Insulet Corporation Recent Developments
4.15 Eli Lilly and Company
4.15.1 Eli Lilly and Company Company Information
4.15.2 Eli Lilly and Company Business Overview
4.15.3 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.15.4 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Portfolio
4.15.5 Eli Lilly and Company Recent Developments
4.16 Debiotech
4.16.1 Debiotech Company Information
4.16.2 Debiotech Business Overview
4.16.3 Debiotech Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.16.4 Debiotech Home Insulin Delivery (Dosing) Devices Product Portfolio
4.16.5 Debiotech Recent Developments
4.17 Dance Biopharm
4.17.1 Dance Biopharm Company Information
4.17.2 Dance Biopharm Business Overview
4.17.3 Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.17.4 Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Portfolio
4.17.5 Dance Biopharm Recent Developments
4.18 Copernicus
4.18.1 Copernicus Company Information
4.18.2 Copernicus Business Overview
4.18.3 Copernicus Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.18.4 Copernicus Home Insulin Delivery (Dosing) Devices Product Portfolio
4.18.5 Copernicus Recent Developments
4.19 Biocon
4.19.1 Biocon Company Information
4.19.2 Biocon Business Overview
4.19.3 Biocon Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.19.4 Biocon Home Insulin Delivery (Dosing) Devices Product Portfolio
4.19.5 Biocon Recent Developments
4.20 Beta Bionics
4.20.1 Beta Bionics Company Information
4.20.2 Beta Bionics Business Overview
4.20.3 Beta Bionics Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.20.4 Beta Bionics Home Insulin Delivery (Dosing) Devices Product Portfolio
4.20.5 Beta Bionics Recent Developments
4.21 BD
4.21.1 BD Company Information
4.21.2 BD Business Overview
4.21.3 BD Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.21.4 BD Home Insulin Delivery (Dosing) Devices Product Portfolio
4.21.5 BD Recent Developments
4.22 B. Braun
4.22.1 B. Braun Company Information
4.22.2 B. Braun Business Overview
4.22.3 B. Braun Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2021-2026)
4.22.4 B. Braun Home Insulin Delivery (Dosing) Devices Product Portfolio
4.22.5 B. Braun Recent Developments
5 Global Home Insulin Delivery (Dosing) Devices Market Scenario by Region
5.1 Global Home Insulin Delivery (Dosing) Devices Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Home Insulin Delivery (Dosing) Devices Sales by Region: 2021-2032
5.2.1 Global Home Insulin Delivery (Dosing) Devices Sales by Region: 2021-2026
5.2.2 Global Home Insulin Delivery (Dosing) Devices Sales by Region: 2027-2032
5.3 Global Home Insulin Delivery (Dosing) Devices Revenue by Region: 2021-2032
5.3.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Region: 2021-2026
5.3.2 Global Home Insulin Delivery (Dosing) Devices Revenue by Region: 2027-2032
5.4 North America Home Insulin Delivery (Dosing) Devices Market Facts & Figures by Country
5.4.1 North America Home Insulin Delivery (Dosing) Devices Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2032)
5.4.3 North America Home Insulin Delivery (Dosing) Devices Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Home Insulin Delivery (Dosing) Devices Market Facts & Figures by Country
5.5.1 Europe Home Insulin Delivery (Dosing) Devices Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2032)
5.5.3 Europe Home Insulin Delivery (Dosing) Devices Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Home Insulin Delivery (Dosing) Devices Market Facts & Figures by Country
5.6.1 Asia Pacific Home Insulin Delivery (Dosing) Devices Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2032)
5.6.3 Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Home Insulin Delivery (Dosing) Devices Market Facts & Figures by Country
5.7.1 South America Home Insulin Delivery (Dosing) Devices Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2032)
5.7.3 South America Home Insulin Delivery (Dosing) Devices Revenue by Country (2021-2032)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Home Insulin Delivery (Dosing) Devices Market Facts & Figures by Country
5.8.1 Middle East and Africa Home Insulin Delivery (Dosing) Devices Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2032)
5.8.3 Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue by Country (2021-2032)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2032)
6.1.1 Global Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2032) & (k units)
6.1.2 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2021-2032)
6.2 Global Home Insulin Delivery (Dosing) Devices Revenue by Type (2021-2032)
6.2.1 Global Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2021-2032)
6.3 Global Home Insulin Delivery (Dosing) Devices Price by Type (2021-2032)
7 Segment by Application
7.1 Global Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2032)
7.1.1 Global Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2032) & (k units)
7.1.2 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2021-2032)
7.2 Global Home Insulin Delivery (Dosing) Devices Revenue by Application (2021-2032)
7.2.1 Global Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2021-2032)
7.3 Global Home Insulin Delivery (Dosing) Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Home Insulin Delivery (Dosing) Devices Value Chain Analysis
8.1.1 Home Insulin Delivery (Dosing) Devices Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Home Insulin Delivery (Dosing) Devices Production Mode & Process
8.2 Home Insulin Delivery (Dosing) Devices Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Home Insulin Delivery (Dosing) Devices Distributors
8.2.3 Home Insulin Delivery (Dosing) Devices Customers
9 Global Home Insulin Delivery (Dosing) Devices Analyzing Market Dynamics
9.1 Home Insulin Delivery (Dosing) Devices Industry Trends
9.2 Home Insulin Delivery (Dosing) Devices Industry Drivers
9.3 Home Insulin Delivery (Dosing) Devices Industry Opportunities and Challenges
9.4 Home Insulin Delivery (Dosing) Devices Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Home Insulin Delivery (Dosing) Devices Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Home Insulin Delivery (Dosing) Devices Sales (k units) of Manufacturers (2021-2026)
Table 7. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Home Insulin Delivery (Dosing) Devices Revenue of Manufacturers (2021-2026)
Table 9. Global Home Insulin Delivery (Dosing) Devices Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Home Insulin Delivery (Dosing) Devices Average Price (USD/unit) of Manufacturers (2021-2026)
Table 11. Global Home Insulin Delivery (Dosing) Devices Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Home Insulin Delivery (Dosing) Devices, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Home Insulin Delivery (Dosing) Devices, Product Type & Application
Table 14. Global Home Insulin Delivery (Dosing) Devices Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Home Insulin Delivery (Dosing) Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Medtronic Company Information
Table 19. Medtronic Business Overview
Table 20. Medtronic Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 21. Medtronic Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 22. Medtronic Recent Developments
Table 23. Ypsomed Holding Company Information
Table 24. Ypsomed Holding Business Overview
Table 25. Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 26. Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 27. Ypsomed Holding Recent Developments
Table 28. Wockhardt Company Information
Table 29. Wockhardt Business Overview
Table 30. Wockhardt Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 31. Wockhardt Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 32. Wockhardt Recent Developments
Table 33. West Pharma Company Information
Table 34. West Pharma Business Overview
Table 35. West Pharma Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 36. West Pharma Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 37. West Pharma Recent Developments
Table 38. Valeritas Company Information
Table 39. Valeritas Business Overview
Table 40. Valeritas Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 41. Valeritas Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 42. Valeritas Recent Developments
Table 43. Tandem Diabetes Care Company Information
Table 44. Tandem Diabetes Care Business Overview
Table 45. Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 46. Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 47. Tandem Diabetes Care Recent Developments
Table 48. SOOIL Company Information
Table 49. SOOIL Business Overview
Table 50. SOOIL Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 51. SOOIL Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 52. SOOIL Recent Developments
Table 53. Sanofi Company Information
Table 54. Sanofi Business Overview
Table 55. Sanofi Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 56. Sanofi Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 57. Sanofi Recent Developments
Table 58. Roche Holding AG Company Information
Table 59. Roche Holding AG Business Overview
Table 60. Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 61. Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 62. Roche Holding AG Recent Developments
Table 63. Owen Mumford Company Information
Table 64. Owen Mumford Business Overview
Table 65. Owen Mumford Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 66. Owen Mumford Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 67. Owen Mumford Recent Developments
Table 68. Novo Nordisk Company Information
Table 69. Novo Nordisk Business Overview
Table 70. Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 71. Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 72. Novo Nordisk Recent Developments
Table 73. MannKind Company Information
Table 74. MannKind Business Overview
Table 75. MannKind Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 76. MannKind Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 77. MannKind Recent Developments
Table 78. Julphar Company Information
Table 79. Julphar Business Overview
Table 80. Julphar Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 81. Julphar Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 82. Julphar Recent Developments
Table 83. Insulet Corporation Company Information
Table 84. Insulet Corporation Business Overview
Table 85. Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 86. Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 87. Insulet Corporation Recent Developments
Table 88. Eli Lilly and Company Company Information
Table 89. Eli Lilly and Company Business Overview
Table 90. Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 91. Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 92. Eli Lilly and Company Recent Developments
Table 93. Debiotech Company Information
Table 94. Debiotech Business Overview
Table 95. Debiotech Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 96. Debiotech Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 97. Debiotech Recent Developments
Table 98. Dance Biopharm Company Information
Table 99. Dance Biopharm Business Overview
Table 100. Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 101. Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 102. Dance Biopharm Recent Developments
Table 103. Copernicus Company Information
Table 104. Copernicus Business Overview
Table 105. Copernicus Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 106. Copernicus Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 107. Copernicus Recent Developments
Table 108. Biocon Company Information
Table 109. Biocon Business Overview
Table 110. Biocon Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 111. Biocon Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 112. Biocon Recent Developments
Table 113. Beta Bionics Company Information
Table 114. Beta Bionics Business Overview
Table 115. Beta Bionics Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 116. Beta Bionics Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 117. Beta Bionics Recent Developments
Table 118. BD Company Information
Table 119. BD Business Overview
Table 120. BD Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 121. BD Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 122. BD Recent Developments
Table 123. B. Braun Company Information
Table 124. B. Braun Business Overview
Table 125. B. Braun Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 126. B. Braun Home Insulin Delivery (Dosing) Devices Product Portfolio
Table 127. B. Braun Recent Developments
Table 128. Global Home Insulin Delivery (Dosing) Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 129. Global Home Insulin Delivery (Dosing) Devices Sales by Region (2021-2026) & (k units)
Table 130. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Region (2021-2026)
Table 131. Global Home Insulin Delivery (Dosing) Devices Sales by Region (2027-2032) & (k units)
Table 132. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Region (2027-2032)
Table 133. Global Home Insulin Delivery (Dosing) Devices Revenue by Region (2021-2026) & (US$ Million)
Table 134. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Region (2021-2026)
Table 135. Global Home Insulin Delivery (Dosing) Devices Revenue by Region (2027-2032) & (US$ Million)
Table 136. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Region (2027-2032)
Table 137. North America Home Insulin Delivery (Dosing) Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 138. North America Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026) & (k units)
Table 139. North America Home Insulin Delivery (Dosing) Devices Sales by Country (2027-2032) & (k units)
Table 140. North America Home Insulin Delivery (Dosing) Devices Revenue by Country (2021-2026) & (US$ Million)
Table 141. North America Home Insulin Delivery (Dosing) Devices Revenue by Country (2027-2032) & (US$ Million)
Table 142. Europe Home Insulin Delivery (Dosing) Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 143. Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026) & (k units)
Table 144. Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2027-2032) & (k units)
Table 145. Europe Home Insulin Delivery (Dosing) Devices Revenue by Country (2021-2026) & (US$ Million)
Table 146. Europe Home Insulin Delivery (Dosing) Devices Revenue by Country (2027-2032) & (US$ Million)
Table 147. Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 148. Asia Pacific Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026) & (k units)
Table 149. Asia Pacific Home Insulin Delivery (Dosing) Devices Sales by Country (2027-2032) & (k units)
Table 150. Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue by Country (2021-2026) & (US$ Million)
Table 151. Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue by Country (2027-2032) & (US$ Million)
Table 152. South America Home Insulin Delivery (Dosing) Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 153. South America Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026) & (k units)
Table 154. South America Home Insulin Delivery (Dosing) Devices Sales by Country (2027-2032) & (k units)
Table 155. South America Home Insulin Delivery (Dosing) Devices Revenue by Country (2021-2026) & (US$ Million)
Table 156. South America Home Insulin Delivery (Dosing) Devices Revenue by Country (2027-2032) & (US$ Million)
Table 157. Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 158. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026) & (k units)
Table 159. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Country (2027-2032) & (k units)
Table 160. Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue by Country (2021-2026) & (US$ Million)
Table 161. Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue by Country (2027-2032) & (US$ Million)
Table 162. Global Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2026) & (k units)
Table 163. Global Home Insulin Delivery (Dosing) Devices Sales by Type (2027-2032) & (k units)
Table 164. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2021-2026)
Table 165. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2027-2032)
Table 166. Global Home Insulin Delivery (Dosing) Devices Revenue by Type (2021-2026) & (US$ Million)
Table 167. Global Home Insulin Delivery (Dosing) Devices Revenue by Type (2027-2032) & (US$ Million)
Table 168. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2021-2026)
Table 169. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2027-2032)
Table 170. Global Home Insulin Delivery (Dosing) Devices Price by Type (2021-2026) & (USD/unit)
Table 171. Global Home Insulin Delivery (Dosing) Devices Price by Type (2027-2032) & (USD/unit)
Table 172. Global Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2026) & (k units)
Table 173. Global Home Insulin Delivery (Dosing) Devices Sales by Application (2027-2032) & (k units)
Table 174. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2021-2026)
Table 175. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2027-2032)
Table 176. Global Home Insulin Delivery (Dosing) Devices Revenue by Application (2021-2026) & (US$ Million)
Table 177. Global Home Insulin Delivery (Dosing) Devices Revenue by Application (2027-2032) & (US$ Million)
Table 178. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2021-2026)
Table 179. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2027-2032)
Table 180. Global Home Insulin Delivery (Dosing) Devices Price by Application (2021-2026) & (USD/unit)
Table 181. Global Home Insulin Delivery (Dosing) Devices Price by Application (2027-2032) & (USD/unit)
Table 182. Key Raw Materials
Table 183. Raw Materials Key Suppliers
Table 184. Home Insulin Delivery (Dosing) Devices Distributors List
Table 185. Home Insulin Delivery (Dosing) Devices Customers List
Table 186. Home Insulin Delivery (Dosing) Devices Industry Trends
Table 187. Home Insulin Delivery (Dosing) Devices Industry Drivers
Table 188. Home Insulin Delivery (Dosing) Devices Industry Restraints
Table 189. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Home Insulin Delivery (Dosing) Devices Product Image
Figure 5. Global Home Insulin Delivery (Dosing) Devices Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Home Insulin Delivery (Dosing) Devices Market Size (2021-2032) & (US$ Million)
Figure 7. Global Home Insulin Delivery (Dosing) Devices Sales (2021-2032) & (k units)
Figure 8. Global Home Insulin Delivery (Dosing) Devices Average Price (USD/unit) & (2021-2032)
Figure 9. Insulin Pumps Product Image
Figure 10. Insulin Pens Product Image
Figure 11. Insulin Syringes Product Image
Figure 12. Others Product Image
Figure 13. Online Pharmacy Product Image
Figure 14. Retail Pharmacy Product Image
Figure 15. Hospitals Pharmacy Product Image
Figure 16. Global Home Insulin Delivery (Dosing) Devices Revenue Share by Manufacturers in 2025
Figure 17. Global Manufacturers of Home Insulin Delivery (Dosing) Devices, Manufacturing Sites & Headquarters
Figure 18. Global Top 5 and 10 Home Insulin Delivery (Dosing) Devices Players Market Share by Revenue in 2025
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 20. Global Home Insulin Delivery (Dosing) Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 21. Global Home Insulin Delivery (Dosing) Devices Sales by Region in 2025
Figure 22. Global Home Insulin Delivery (Dosing) Devices Revenue by Region in 2025
Figure 23. North America Home Insulin Delivery (Dosing) Devices Market Size by Country in 2025
Figure 24. North America Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2021-2032)
Figure 25. North America Home Insulin Delivery (Dosing) Devices Revenue Market Share by Country (2021-2032)
Figure 26. United States Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Canada Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 28. Mexico Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 29. Europe Home Insulin Delivery (Dosing) Devices Market Size by Country in 2025
Figure 30. Europe Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2021-2032)
Figure 31. Europe Home Insulin Delivery (Dosing) Devices Revenue Market Share by Country (2021-2032)
Figure 32. Germany Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. France Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. U.K. Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Italy Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Russia Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Spain Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Netherlands Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Switzerland Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Sweden Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Poland Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Asia Pacific Home Insulin Delivery (Dosing) Devices Market Size by Country in 2025
Figure 43. Asia Pacific Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2021-2032)
Figure 44. Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue Market Share by Country (2021-2032)
Figure 45. China Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. Japan Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. South Korea Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. India Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Australia Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Taiwan Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Southeast Asia Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Southeast Asia Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 53. South America Home Insulin Delivery (Dosing) Devices Market Size by Country in 2025
Figure 54. South America Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2021-2032)
Figure 55. South America Home Insulin Delivery (Dosing) Devices Revenue Market Share by Country (2021-2032)
Figure 56. Brazil Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Argentina Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Chile Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 59. Middle East and Africa Home Insulin Delivery (Dosing) Devices Market Size by Country in 2025
Figure 60. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2021-2032)
Figure 61. Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue Market Share by Country (2021-2032)
Figure 62. Egypt Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. South Africa Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. Israel Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. Türkiye Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 66. GCC Countries Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 67. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2021-2032)
Figure 68. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2021-2032)
Figure 69. Global Home Insulin Delivery (Dosing) Devices Price (USD/unit) by Type (2021-2032)
Figure 70. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2021-2032)
Figure 71. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2021-2032)
Figure 72. Global Home Insulin Delivery (Dosing) Devices Price (USD/unit) by Application (2021-2032)
Figure 73. Home Insulin Delivery (Dosing) Devices Value Chain
Figure 74. Home Insulin Delivery (Dosing) Devices Production Mode & Process
Figure 75. Direct Comparison with Distribution Share
Figure 76. Distributors Profiles
Figure 77. Home Insulin Delivery (Dosing) Devices Industry Opportunities and Challenges
提及公司
MedtronicYpsomed HoldingWockhardtWest PharmaValeritasTandem Diabetes CareSOOILSanofiRoche Holding AGOwen MumfordNovo NordiskMannKindJulpharInsulet CorporationEli Lilly and CompanyDebiotechDance BiopharmCopernicusBioconBeta BionicsBDB. Braun
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們